Latest Pneumococcal vaccine Stories
Kaiser Permanente used electronic health records to study 84,000 men.
Men 45 years or older who received pneumococcal vaccine were not less likely to have a heart attack or stroke compared to men who did not receive the vaccine.
BETHESDA, Md., April 26 /PRNewswire/ -- Scientists at the 13th Annual Conference on Vaccine Research (ACVR), sponsored by the National Foundation for Infectious Diseases (NFID), will reflect on the remarkable growth of vaccine biotechnology in the last several decades and focus on the growing number of challenging illnesses that may become vaccine-preventable or vaccine-treatable in the coming years.
Two of the largest pharmaceutical companies in the world have agreed to a 10-year commitment to supply new pneumonia vaccines to developing nations across the globe.
LONDON, March 23 /PRNewswire-FirstCall/ -- GSK (NYSE: GSK) has become one of the first manufacturers to sign a unique agreement with the GAVI Alliance (GAVI) that has the potential to save millions of children from dying in the world's poorest countries.
The Global Alliance on Vaccines and Immunization (GAVI) said on Monday that a further 4 billion dollars is needed if the global vaccines alliance is to meet its goal of supplying life-saving immunizations to millions of children in poor countries by 2015.
A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa.
The pneumococcal vaccine for infants and children introduced in 2000 caused a precipitous drop in infections until 2005, when serious illnesses began to rise again, especially infections caused by a strain of the pneumococcal bacteria called 19A, said researchers from Baylor College of Medicine and Texas Children's Hospital in a report in the current issue of the journal Pediatrics.
Finds Low Adult Vaccination Rates in U.S.